- Home
- MNSO vs NUVL Comparison
MNSO vs NUVL Comparison
Compare MNSO & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSO
- NUVL
- Stock Information
- Founded
- MNSO 2013
- NUVL 2017
- Country
- MNSO China
- NUVL United States
- Employees
- MNSO N/A
- NUVL N/A
- Industry
- MNSO Department/Specialty Retail Stores
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- MNSO Consumer Discretionary
- NUVL Health Care
- Exchange
- MNSO Nasdaq
- NUVL Nasdaq
- Market Cap
- MNSO 6.8B
- NUVL 7.2B
- IPO Year
- MNSO 2020
- NUVL 2021
- Fundamental
- Price
- MNSO $21.78
- NUVL $92.33
- Analyst Decision
- MNSO Strong Buy
- NUVL Strong Buy
- Analyst Count
- MNSO 2
- NUVL 12
- Target Price
- MNSO $24.10
- NUVL $123.33
- AVG Volume (30 Days)
- MNSO 694.0K
- NUVL 588.0K
- Earning Date
- MNSO 11-21-2025
- NUVL 10-30-2025
- Dividend Yield
- MNSO 3.00%
- NUVL N/A
- EPS Growth
- MNSO N/A
- NUVL N/A
- EPS
- MNSO 1.06
- NUVL N/A
- Revenue
- MNSO $2,600,350,931.00
- NUVL N/A
- Revenue This Year
- MNSO $27.70
- NUVL N/A
- Revenue Next Year
- MNSO $19.11
- NUVL N/A
- P/E Ratio
- MNSO $19.58
- NUVL N/A
- Revenue Growth
- MNSO 21.03
- NUVL N/A
- 52 Week Low
- MNSO $13.95
- NUVL $55.54
- 52 Week High
- MNSO $27.71
- NUVL $104.90
- Technical
- Relative Strength Index (RSI)
- MNSO 50.06
- NUVL 51.50
- Support Level
- MNSO $20.35
- NUVL $89.38
- Resistance Level
- MNSO $21.60
- NUVL $95.93
- Average True Range (ATR)
- MNSO 0.44
- NUVL 5.08
- MACD
- MNSO -0.02
- NUVL -0.90
- Stochastic Oscillator
- MNSO 57.56
- NUVL 22.58
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.